← back to search

Valeria Panebianco

Université Claude Bernard Lyon 1 · FR
🔎 Find collaborators in Pulmonary and Respiratory Medicine · Surgery →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Prostate Cancer Diagnosis and Treatment, Prostate Cancer Treatment and Research, Bladder and Urothelial Cancer Treatments, and MRI in cancer diagnosis.
h-index
48
citations
11,776
works
268
NIH funding
primary concept
Medicine
email

Recent publications

Primary Noncontrast Magnetic Resonance Imaging for Prostate Cancer Screening: A Randomized Clinical Trial (PROSA)
European Urology 2026cited by 8position: contributordoi
Contrast-free MRI-first screening in young asymptomatic men: Prostate characteristics and cancer detection rates.
2026cited by 0position: contributordoi
PRECISE Version 2: Essential Tips for Prostate Cancer Monitoring Using MRI.
2026cited by 0position: contributordoi
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus.
2026cited by 0position: contributordoi
Biparametric vs Multiparametric MRI for Prostate Cancer Diagnosis
JAMA 2025cited by 40position: middledoi
Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naive Men: PI-RADS Steering Committee, Version 1.0
Radiology 2025cited by 12position: middledoi
The Dublin International Society of Urological Pathology (ISUP) Consensus Conference on Best Practice Recommendations on the Pathology of Urachal Neoplasms
The American Journal of Surgical Pathology 2025cited by 10position: middledoi
Multiparametric Magnetic Resonance Imaging and Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnosis and Staging: A Guide for Clinicians from the American College of Radiology VI-RADS Steering Committee
European Urology 2025cited by 8position: firstdoi
Multiparametric MRI for Bladder Cancer: A Practical Approach to the Clinical Application of VI-RADS.
2025cited by 8position: contributordoi
Multiparametric Magnetic Resonance Imaging and Vesical Imaging-Reporting and Data System (VI-RADS) for Bladder Cancer Diagnosis and Staging: A Guide for Clinicians from the American College of Radiology VI-RADS Steering Committee
European Urology 2025cited by 8position: contributordoi
Requirements for AI Development and Reporting for MRI Prostate Cancer Detection in Biopsy-Naive Men: PI-RADS Steering Committee, Version 1.0.
2025cited by 7position: contributordoi
The Dublin International Society of Urological Pathology (ISUP) Consensus Conference on Best Practice Recommendations on the Pathology of Glandular Lesions of the Urinary Bladder
Advances in Anatomic Pathology 2025cited by 4position: middledoi
VI-RADS followed by Photodynamic Transurethral Resection of Non-Muscle-Invasive Bladder Cancer vs White-Light Conventional and Second-resection: the 'CUT-less' Randomised Trial Protocol.
2025cited by 3position: contributordoi
MicroRNA and renal fibrosis in autosomal dominant polycystic kidney disease: a longitudinal study.
2025cited by 0position: contributordoi
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2023 Guidelines.
2024cited by 423position: contributordoi
Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study.
2024cited by 163position: contributordoi
PI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI.
2024cited by 93position: contributordoi
PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer
European Urology 2024cited by 56position: middledoi
PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer.
2024cited by 35position: contributordoi
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer.
2024cited by 29position: contributordoi
Clinical application of bladder MRI and the Vesical Imaging-Reporting and Data System.
2024cited by 26position: contributordoi
Design of a magnetic resonance imaging-based screening program for early diagnosis of prostate cancer: preliminary results of a randomized controlled trial-Prostate Cancer Secondary Screening in Sapienza (PROSA).
2024cited by 15position: contributordoi
The Role of Multiparametric Magnetic Resonance Imaging and the Vesical Imaging-Reporting and Data System (VI-RADS) in the Management of Patients with Bladder Cancer: Vision of the American College of Radiology VI-RADS Steering Committee
European Urology 2024cited by 14position: firstdoi
The performance of the node reporting and data system 1.0 (Node-RADS) and DWI-MRI in staging patients with cervical carcinoma according to the new FIGO classification (2018).
2024cited by 13position: contributordoi
Quality of T2-weighted MRI re-acquisition versus deep learning GAN image reconstruction: A multi-reader study.
2024cited by 9position: contributordoi
Lung ultrasound compared to computed tomography detection and automated quantification of systemic sclerosis-associated interstitial lung disease: preliminary study.
2024cited by 8position: contributordoi
Advanced and traditional chest MRI sequence for the clinical assessment of systemic sclerosis related interstitial lung disease, compared to CT: disease extent analysis and correlations with pulmonary function tests.
2024cited by 8position: contributordoi
MRI for risk stratification of muscle invasion by upper tract urothelial carcinoma: a feasibility study.
2024cited by 7position: contributordoi
VI‐RADS followed by Photodynamic Transurethral Resection of Non‐Muscle‐Invasive Bladder Cancer vs White‐Light Conventional and Second‐resection: the ‘CUT‐ <i>less</i> ’ Randomised Trial Protocol
British Journal of Urology 2024cited by 4position: middledoi
Evaluation of Prostate Cancer Recurrence with MR Imaging and Prostate Imaging for Recurrence Reporting Scoring System.
2024cited by 4position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 26 papers (2020–2026)Caroline M. Moore · University College London Hospitals NHS Foundation Trust16 papers (2016–2026)James W.F. Catto · University of Sheffield15 papers (2018–2024)Jelle O. Barentsz · AkzoNobel (Netherlands)14 papers (2018–2023)Anwar R. Padhani · Complejo Hospitalario Universitario de Santiago12 papers (2020–2025)Olivier Rouvière · Université Claude Bernard Lyon 110 papers (2019–2025)Francesco Giganti · University College London Hospitals NHS Foundation Trust9 papers (2016–2026)Masoom A. Haider · University of Toronto9 papers (2016–2025)Tristan Barrett · Institut Paoli-Calmettes9 papers (2020–2026)Benjamin I. Chung · Palo Alto University8 papers (2020–2025)Giuseppe Simone · Sapienza University of Rome8 papers (2019–2024)Ivo G. Schoots · Erasmus MC7 papers (2016–2025) · 7 papers (2020–2026)Gian Maria Busetto · Sapienza University of Rome7 papers (2020–2023)Francesco Del Giudice · Sapienza University of Rome7 papers (2020–2025)Geert Villeirs · Whipps Cross University Hospital7 papers (2019–2022)Barış Türkbey · Cancer Institute (WIA)6 papers (2016–2025)Anwar R. Padhani · Complejo Hospitalario Universitario de Santiago6 papers (2016–2025)Veeru Kasivisvanathan · University of Turin6 papers (2016–2024)Jason A. Efstathiou · Harvard University6 papers (2018–2025)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Pulmonary and Respiratory Medicine · Surgery →